Safety of Mesenchymal Stem Cells Therapy in Patients With Inflammatory Bowel Diseases - 5 Year Follow-Up
Enliven: Genetics, Molecular, and Cellular Biology
doi 10.18650/2379-5700.22003
Full Text
Open PDFAbstract
Available in full text
Date
July 24, 2015
Authors
Publisher
Enliven Archive